ZA200705069B - Tri (hydrocymethyl) methylamine salt or an ethanol amine salt of (2S) -2-ethoxy-3-(4-{-2-[hexyl(2-phenylethyl) amino]-2-oxoethoxy} phenyl) propanoic acid - Google Patents

Tri (hydrocymethyl) methylamine salt or an ethanol amine salt of (2S) -2-ethoxy-3-(4-{-2-[hexyl(2-phenylethyl) amino]-2-oxoethoxy} phenyl) propanoic acid

Info

Publication number
ZA200705069B
ZA200705069B ZA200705069A ZA200705069A ZA200705069B ZA 200705069 B ZA200705069 B ZA 200705069B ZA 200705069 A ZA200705069 A ZA 200705069A ZA 200705069 A ZA200705069 A ZA 200705069A ZA 200705069 B ZA200705069 B ZA 200705069B
Authority
ZA
South Africa
Prior art keywords
salt
hydrocymethyl
oxoethoxy
phenylethyl
ethoxy
Prior art date
Application number
ZA200705069A
Other languages
English (en)
Inventor
Rebecca J Booth
Dahlstroem Mikael
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Publication of ZA200705069B publication Critical patent/ZA200705069B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C235/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
    • C07C235/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton
    • C07C235/04—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton the carbon skeleton being acyclic and saturated
    • C07C235/18—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton the carbon skeleton being acyclic and saturated having at least one of the singly-bound oxygen atoms further bound to a carbon atom of a six-membered aromatic ring, e.g. phenoxyacetamides
    • C07C235/20—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton the carbon skeleton being acyclic and saturated having at least one of the singly-bound oxygen atoms further bound to a carbon atom of a six-membered aromatic ring, e.g. phenoxyacetamides having the nitrogen atoms of the carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C215/00—Compounds containing amino and hydroxy groups bound to the same carbon skeleton
    • C07C215/02—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C215/04—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being saturated
    • C07C215/06—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being saturated and acyclic
    • C07C215/08—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being saturated and acyclic with only one hydroxy group and one amino group bound to the carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C215/00—Compounds containing amino and hydroxy groups bound to the same carbon skeleton
    • C07C215/02—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C215/04—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being saturated
    • C07C215/06—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being saturated and acyclic
    • C07C215/10—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being saturated and acyclic with one amino group and at least two hydroxy groups bound to the carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C229/02—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C229/04—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
    • C07C229/06—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one amino and one carboxyl group bound to the carbon skeleton
    • C07C229/18—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one amino and one carboxyl group bound to the carbon skeleton the nitrogen atom of the amino group being further bound to carbon atoms of six-membered aromatic rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Child & Adolescent Psychology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
ZA200705069A 2004-12-16 2007-06-12 Tri (hydrocymethyl) methylamine salt or an ethanol amine salt of (2S) -2-ethoxy-3-(4-{-2-[hexyl(2-phenylethyl) amino]-2-oxoethoxy} phenyl) propanoic acid ZA200705069B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE0403072A SE0403072D0 (sv) 2004-12-16 2004-12-16 Pharmaceutically useful salts of carboxylic acid derivates

Publications (1)

Publication Number Publication Date
ZA200705069B true ZA200705069B (en) 2008-10-29

Family

ID=34075233

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200705069A ZA200705069B (en) 2004-12-16 2007-06-12 Tri (hydrocymethyl) methylamine salt or an ethanol amine salt of (2S) -2-ethoxy-3-(4-{-2-[hexyl(2-phenylethyl) amino]-2-oxoethoxy} phenyl) propanoic acid

Country Status (17)

Country Link
US (1) US20080114064A1 (zh)
EP (1) EP1831151A4 (zh)
JP (1) JP2008524209A (zh)
KR (1) KR20070087122A (zh)
CN (1) CN101080383A (zh)
AR (1) AR055006A1 (zh)
AU (1) AU2005317285A1 (zh)
BR (1) BRPI0519029A2 (zh)
CA (1) CA2589519A1 (zh)
IL (1) IL183529A0 (zh)
MX (1) MX2007007209A (zh)
NO (1) NO20072873L (zh)
RU (1) RU2007126748A (zh)
SE (1) SE0403072D0 (zh)
TW (1) TW200635879A (zh)
WO (1) WO2006065214A1 (zh)
ZA (1) ZA200705069B (zh)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE0104334D0 (sv) * 2001-12-19 2001-12-19 Astrazeneca Ab Therapeutic agents
GB0314129D0 (en) * 2003-06-18 2003-07-23 Astrazeneca Ab Therapeutic agents

Also Published As

Publication number Publication date
CN101080383A (zh) 2007-11-28
JP2008524209A (ja) 2008-07-10
TW200635879A (en) 2006-10-16
WO2006065214A1 (en) 2006-06-22
EP1831151A4 (en) 2010-06-30
BRPI0519029A2 (pt) 2008-12-23
RU2007126748A (ru) 2009-01-27
CA2589519A1 (en) 2006-06-22
US20080114064A1 (en) 2008-05-15
NO20072873L (no) 2007-06-21
AR055006A1 (es) 2007-08-01
SE0403072D0 (sv) 2004-12-16
EP1831151A1 (en) 2007-09-12
MX2007007209A (es) 2007-08-15
IL183529A0 (en) 2007-09-20
AU2005317285A1 (en) 2006-06-22
KR20070087122A (ko) 2007-08-27

Similar Documents

Publication Publication Date Title
EP2096176A4 (en) PROCESS FOR OBTAINING CRYSTALS OF THE HYDROCHLORIDE OF A BASIC AMINO ACID
BRPI0716539A2 (pt) métodos para sintetização de ácido n-(8-[2-hidroxibenzoil]amino) caprílico e de sal de sódio deste
DK2035554T3 (da) Celle-fri syntese af proteiner indeholdende ikke-naturlige aminosyrer
IL190483A0 (en) Methods for use of branched chain amino acids
SMT201400142B (it) Composti di N-(1H-indazol-4-il) immidazo[1,2-A]piridin-3-carbossammide sostituita come inibitori di cfms
HK1200164A1 (zh) 谷氨酸的異質二聚體
EP2326643A4 (en) BENZOCHINOL INHIBITOR OF VESICLE MONOAMINE TRANSPORTER 2
SI1999259T1 (sl) Usmerjeno vključevanje amino kislin v molekule
EP1809758A4 (en) LOCAL IN VIVO INSTALLATION OF N-ACETYLGALACTOSAMINE AMINO ACIDS IN EU BACTERIA
ATE520684T1 (de) Neue carbonsäureamide als faktor xa-inhibitoren
IL195313A0 (en) Substituted beta-phenyl-alpha-hydroxy propanoic acid synthesis method and use thereof
ATE478849T1 (de) 4-anilinochinolin-3-carbonsäureamide als csf-1r- kinaseinhibitoren
PL1853279T3 (pl) Pochodne amidowe kwasu hialuronowego w chorobie zwyrodnieniowej stawów
IL194874A0 (en) Processes for the prepartion of r-(+)-3-(carbomoyl methyl)-5-methylhexanoic acid and salts thereof
IL193481A0 (en) 4-phenyl-thiazole-5-carboxylic acids and 4 - phenyl - thiazole - 5 - carboxylic acid amides as plk1 inhibitors
IL191819A0 (en) Inhibitors of fatty acid amide hydrolase
ZA200805473B (en) Inhibitors of fatty acid amide hydrolase
EA201071001A1 (ru) Способ получения комбретастатина
ZA200803206B (en) Crystalline forms of the di-sodium salt of N-(5-chlorosalicyloyl)-8-aminocaprylic acid
ZA200705069B (en) Tri (hydrocymethyl) methylamine salt or an ethanol amine salt of (2S) -2-ethoxy-3-(4-{-2-[hexyl(2-phenylethyl) amino]-2-oxoethoxy} phenyl) propanoic acid
EP1971333A4 (en) AMINO ACID DERIVATIVES OF PROTEIN KINASE INHIBITORS ON INDOLINONE BASE
EP1632476A4 (en) ACIDIC ACID SALT OF A CARBAZUCKERAMINE DERIVATIVE
BRPI0616418A2 (pt) método para produzir um l-aminoácido
BRPI0616421A2 (pt) método para produzir um l-aminoácido
FR2929289B1 (fr) Base pour bouillon d'enrichissement pour listeria en 24 heures